By creating medicines to control the expression of genes that have gone awry in disease, we aim to make a profound difference in the lives of patients and their families.
At the heart of all our efforts at Syros is our dedication to advancing medicines that provide a profound benefit for patients with difficult-to-treat diseases.
We currently have one program in a Phase 2 clinical trial in patients with acute myeloid leukemia. We have additional programs in earlier stages of research for cancer and genetic disorders, including sickle cell disease.
Interested in participating in a clinical trial?